The more experienced I become as I progress through my career, the more aware I become of the importance of partnership in business. But what does partnership actually mean? It is certainly true that it is a word often bandied about to mean whatever potential clients might want it to...
R&D Funding Strategy Checklist
If your R&D team are not yet back to ‘business as usual’ or a ‘new normal’, we’re here to give a little inspiration for how they could spend the downtime, to positively affect your R&D funding strategy in the future. We’re all adjusting and adapting to the changes that Coronavirus...
BioCity signs The Time to Change employer pledge as part of their CSR strategy
Pioneering life science incubator and business collective, BioCity Group has signed the Time to Change Employer Pledge, making a commitment to changing the way we all think and act about mental health in the workplace. BioCity, which has headquarters in Nottingham and locations in Glasgow and Alderley Park aims to raise awareness of...
The demise of Privacy Shield…
... is causing widespread aftershocks for international personal data transfers to the US…and elsewhere! At the end of last week, the European Court of Justice (CJEU) provided the 'Schrems II’ judgment. It is something which is already causing widespread shudders - not only for those involved in transferring personal data to the US, but...
Building a thriving supply chain
Partner at Medilink EM Patron Mills and Reeve LLP, Jayne Hussey, discusses the future of supply chains in the first of a series of articles with particular focus around the coronavirus impact and potential opportunities. #6 Visibility over the Supply Chain: Using blockchain to minimise disruptions and enhance reputation As...
Taking care of your IP for 20 years
As AdamsonJones looks forward to celebrating 20 years in business on 1 August, we wish to thank all our staff, clients and colleagues for their ongoing commitment to intellectual property (IP) protection. Now more than ever we are grateful to be able to continue working with such a diverse and industrious range...
SurePulse Lands £1m Investment To Expand Its Share Of Neonatal Healthtech Market
The company behind a revolutionary newborn baby heartbeat monitoring device is set to explore foreign markets and grow its product portfolio thanks to £1m secured from existing and new, private investors. SurePulse Medical Ltd, based at Medicity in Nottingham, was established in 2014 as a joint venture between the University...
Locate Bio raises £2.25m for new spinal treatments
Locate Bio, who are developing new treatments for patients with serious spinal conditions, has completed a £2.25m funding round led by Mercia Asset Management to help to continue its ground-breaking research and bring its first products to market. Locate Bio has secured the investment from Mercia’s own balance sheet, its EIS...
PROTAC Assays – Successfully measuring Protein Degradation
PROTAC (PROteolysis TArgeting Chimera) is one of the hottest topics in drug discovery today as it is a highly promising new approach to targeted therapy. It offers several advantages over traditional occupancy-based drugs, with a potential to target the ‘undruggable’ proteome. Read Aurelia Bioscience's blog below to learn more about PROTAC...
A Practical Guide to Developing Software For Medical Devices
In eg Technology's final webinar of their Product Design and Development of Medical Device series, in association with SEHTA, eg technology Director, David Warwick, used his extensive knowledge and experience of computer systems engineering and medical device design to talk us through some practical advice on the development of software...